or
forgot password

Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases


N/A
18 Years
N/A
Open (Enrolling)
Both
Bone Metastases

Thank you

Trial Information

Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases


Inclusion Criteria:



- ≥ to 18 years of age

- Diagnosed with a metastatic malignancy

- histologically proven in oligometastatic disease or by clinical suspicion in widely
metastatic disease

- by conventional radiographs, cross sectional imaging and/or scintigraphy

- Scheduled for an orthopaedic operative intervention for skeletal metastases at MSKCC
including, not limited to the following:

- Resection

- Intramedullary Fixation

- Prophylactic fixation

- Curettage and cementation

- Internal fixation

- Arthroplasty

- Spine stabilization

Exclusion Criteria:

- None

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

serum inflammatory cytokines

Outcome Description:

Whether the addition of serum inflammatory cytokines improves the robustness of an existing, validated Bayesian Belief network trained to estimate survival in human patients with operative skeletal metastases.

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

John Healey, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

11-121

NCT ID:

NCT01470105

Start Date:

November 2011

Completion Date:

November 2014

Related Keywords:

  • Bone Metastases
  • questionnaire
  • 11-121
  • Neoplasm Metastasis
  • Neoplasms, Second Primary
  • Bone Neoplasms
  • Bone Marrow Diseases

Name

Location
Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York  10021
Naval Medical Research Center Bethesda, Maryland  20889